The coagulation system has gained much interest again as new anticoagulatory substances
have been introduced into clinical practice. Especially patients with renal failure are likely …

INTRODUCTION: Patients with chronic kidney disease exhibit features of a hypercoagulable
state and have endothelial dysfunction, which may contribute to their increased …

Hemodialysis (HD) patients have accelerated cardiovascular morbidity and mortality rates
compared with the general population. Identifying the factors that predict major coronary …

Hemostasis is a process of blood clot formation at the site of vessel injury. When a blood
vessel wall breaks, the hemostatic response must be quick, localized, and carefully …

Background Despite cardiovascular diseases and thrombosis being major causes of death
in patients with chronic kidney disease (CKD), there remains no effective biomarker to …

En-stage renal disease (ESRD) is a growing public health problem. The atherosclerotic
cardiovascular complications are the leading causes of mortality and morbidity in the ESRD …

Background Patients with chronic kidney disease (CKD) tend to experience both thrombotic
and hemorrhagic complications; however, the pathophysiology remains unclear. This study …

Venous thromboembolic disease is considered an uncommon event in the end-stage renal
disease (ESRD) population. We report five cases of venous thromboembolism (VTE) …

Patients dialyzed due to diabetic nephropathy are at a higher risk of death due to
cardiovascular complications than dialyzed non-diabetic patients. Disturbances in …

Hemostatic disorders associated with chronic renal failure (CRF) include hemorrhagic
and/or thrombotic manifestations, which were ascribed, in part, to uremic platelet dysfunction …